Archives

Read More

This article was originally published on Medtech Intelligence   Fueled by an urgent need for diagnostic testing to respond to the COVID-19 pandemic, the in-vitro diagnostics (IVD) market is experiencing explosive growth across Asia and around the globe. Already expanding for the... Read More

With more than 55 people dying in China of cancer every ten minutes, the country is innovating treatments and pushing to close deep gaps in fundamental care to meet its oncology crisis. Compared with the United States, the death rate from cancer... Read More

A groundbreaking public welfare foundation in China dedicated to combating rare diseases has announced a major effort to help fund treatments for patients afflicted by such disorders. The assistance program is being launched by the Illness Challenge Foundation, which focuses on bettering... Read More

This article was originally published on MedTech Intelligence  China In China, where the vast medical device market was valued at more than $40 billion in 2019, authorities have moved to secure the safety and efficacy of medical devices while at the same... Read More

Introduction to China’s Drug Market Everyone has been talking about opportunities in China’s drug market the last 5 years. While the size of the drug market in China varies, we estimate it at about $140 billion dollars now and growing about 10%... Read More

Medical device manufacturers seeking to market their products in China will be required to adhere to new guidelines in the risk assessments they submit to authorities, the National Medical Products Administration (NMPA) announced in August. The periodic risk assessment reports, which outline... Read More

Changes to pharmaceutical registration regulations in China that went into effect July 1 make clear that Market Authorization Holders designated by the country’s regulatory authority to market or distribute a product are responsible for the safety, quality, and efficacy of that product... Read More

In a bid to better standardize its assessment of medical devices, China’s Center for Medical Device Evaluation has published revised catalogs of medical devices and in vitro diagnostic reagents that are exempt from clinical trials. The “New and Revised Catalogue of Medical... Read More

Chemical and biologic drugs are required to be classified into new categories for registration in China under new guidance issued by the Center for Drug Evaluation of National Medical Products Administration.    Under the new classification system, which went into effect on... Read More